| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3e44e8a7bad23cd72efd76db5bde60b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 |
| filingDate |
1990-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6555cbff2082557ee0884f31ea355a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ae641272826b015676450189c0b43e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8837bd6a0e64254c4d1bd31bf9d9c0d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d45803e96e012f6a3fda0409f0e5ad0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_700a02170bcc0091815bbb303efd4d6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00be9668bb0cd353e7a8db8cdc5e2f81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df3301074bb6a9255d1304beaa4227f0 |
| publicationDate |
1990-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0385468-A1 |
| titleOfInvention |
A stabilized antitumor composition |
| abstract |
According to this invention there is provided a new stabilized antitumor composition comprising a mixture of an antitumor anthracycline compound of formula (I)n or a non-toxic salt thereof with lactose, with the lactose being incorporated as a stabilizing agent in the mixture in an amount effective to stabilize the anthracycline compound of formula (I) or its salt from its degradation and thus with the weight ratio between the anthracycline compound or its salt and lactose being in a range of 1 : 0.5 to 1 : 8. There is also provided a method for stabilizing the anthracycline compound of formula (I) or its salt by mixing with lactose in the required proportions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108159005-A |
| priorityDate |
1989-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |